Heather McSharry - Aug 11, 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Adam Guttmann as attorney in fact For: Heather Ann McSharry
Stock symbol
JAZZ
Transactions as of
Aug 11, 2023
Transactions value $
-$185,685
Form type
4
Date filed
8/15/2023, 05:52 PM
Previous filing
Aug 9, 2022
Next filing
Aug 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +3.08K +20.44% $0.00 18.1K Aug 11, 2023 Direct F1
transaction JAZZ Ordinary Shares Sale -$186K -1.34K -7.42% $138.16 16.8K Aug 14, 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.
F2 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F3 Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $137.78 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.